Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients
07:04am, Tuesday, 17'th Feb 2026
Teva and Sanofi SA (NASDAQ: SNY) released positive results on Tuesday from the RELIEVE UCCD long-term extension study of duvakitug, an investigational human monoclonal antibody targeting TL1A.
Teva will hold an investor call and live webcast today, Tuesday, February 17, 2026, at 8:00 a.m. ET to discuss these data.
Sanofi and Teva's duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn's disease
Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees
07:07am, Monday, 16'th Feb 2026
French drugmaker Sanofi said on Monday it will expand its global capability centre (GCC) in the southern Indian city of Hyderabad, and increase its workforce to more than 4,500 employees.
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
01:00am, Monday, 16'th Feb 2026
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV
Atria Investments Inc Has $5.54 Million Stock Holdings in Sanofi $SNY
05:46am, Sunday, 15'th Feb 2026
Atria Investments Inc trimmed its position in Sanofi (NASDAQ: SNY) by 12.2% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 117,300 shares of the company
Assetmark Inc. Increases Stake in Sanofi $SNY
05:02am, Sunday, 15'th Feb 2026
Assetmark Inc. boosted its stake in shares of Sanofi (NASDAQ: SNY) by 25.0% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Caprock Group LLC Makes New Investment in Sanofi $SNY
04:12am, Sunday, 15'th Feb 2026
Caprock Group LLC acquired a new stake in shares of Sanofi (NASDAQ: SNY) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Weekend Morning Brew: AI Jitters, Novo--Hims Clash, McDonald's Beat
07:37am, Saturday, 14'th Feb 2026
Weekly Market HighlightsWeekly breadth was slightly negative with 4,703 advancers versus 4,832 decliners, even as 963 stocks gained more than 10% and 1,151 fel
SNY Stock Falls After Board Suddenly Makes Leadership Change
01:55pm, Friday, 13'th Feb 2026
Sanofi stock slides 4.5% after it decides not to renew CEO Paul Hudson's mandate and names Belen Garijo as successor amid investor skepticism.
Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors
08:23am, Friday, 13'th Feb 2026
Sanofi SA (NASDAQ: SNY) shares are down during Friday's premarket session as the company faces leadership changes amid ongoing challenges in its drug pipeline.
First Look: Tech-led selloff, tariff shifts, AI funding boom
07:38am, Friday, 13'th Feb 2026
Stock News Tech slump hits indexes: A broad risk-off move saw Apple (AAPL) and Cisco (CSCO) lead declines, while Applied Materials (AMAT) rallied on upbeat AI t
Sanofi's new CEO needs to fix drug pipeline and navigate Trump
01:03am, Friday, 13'th Feb 2026
Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug development pipeline and navigate vaccine scepticism in the Uni
Market Today: Tech Sells Off on AI Jitters; M&A, FDA Moves and Policy Shifts
05:35pm, Thursday, 12'th Feb 2026
Guru Stock PicksAl Gore has made the following transactions:Reduce in NTNX by 46.77%Sold out in MCHPAdd in MELI by 2.52%New position in CSLKen Fisher has made t
Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued
04:45pm, Thursday, 12'th Feb 2026
Sanofi reported FY net sales up >9% to €43.6bn and net income up >12% to €9.5mn. Despite strong results, Sanofi announced today it has replaced CEO Paul Hudson with former employee Belén Garijo,
